Forschungsprojekte
Ergebnisse pro Seite:
25
2017 - 2020
"Validierung neuer Biomarker der Leberschädigung und Hepatokarzinogenese bei Patienten- Dr. YvonneHuber
2017 - 2021
SEAL - Structured Early Assessment of Asymptomatic Liver Fibrosis and Cirrhosis- Univ.-Prof. Dr. Peter RobertGalle
2017 - 2020
Liver function decline prediction in patients with hepatocellular carcinoma undergoing TACE using LiMAx (TACE-LiMAx)- PD Dr. Marcus-AlexanderWörns
2017 - 2020
Neue anti-fibrotische Makrolactone zur Behandlung progredienter chronischer Nierenerkrankungen.- PD Dr. JuliaWeinmann-Menke
2017 - 2019
Inneruniversitäre Forschung Stufe I der Universitätsmedizin Mainz, 2017-2018 SLEEP-Studie (Systemic Lupus Erythematodes Exercise Program)- PD Dr. JuliaWeinmann-Menke
2017 - 2020
S-AVANT – Follow-up to the AVANT study up to 8 and 10 years (median follow up) in patients with colon carcinoma- Prof. Dr. MarkusMöhler
2016 - 2020
A Phase III open-label, multicenter trial of maintenance therapy with Avelumab* (MSB0010718C) versus continuation of first-line chemotherapy in subjects with unresectable, locally advanced or metastatic adenocarcinoma of the stomach or of the gastro-esophageal junction- Prof. Dr. MarkusMöhler
2016 - 2019
Analysis of ACPAs in patients with very early rheumatoid arthritis (VERA) and patients with yet unclassified arthritis (UA) in the Rheumatology network ADAPTHERA- Univ.-Prof. Dr. AndreasSchwarting
2016 - 2018
Guideline Programme-Oncology: Update of the guideline gastric carcinoma (S3)- Prof. Dr. MarkusMöhler
2016 - 2018
CFZ 533: An open label study to evaluate the safety and efficacy of 12 week treatment with CFZ533 in patients with Graves' disease- Prof. Dr. Georg J.Kahaly